Tianeptine in combination with monoamine oxidase inhibitors for major depressive disorder

2Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Major depressive disorder may respond to monotherapy with monoamine oxidase inhibitors (MAOIs) or tianeptine. Literature search showed no reports of MAOIs combined with tianeptine. The method included was clinical case history. A 59-year-old woman had partial improvement of depression with the MAOI tranylcypromine combined with topiramate, trazodone and ziprasidone. The patient had further improvement of depression symptoms after addition of tianeptine. No adverse events were evident. The combination of MAIOs and tianeptine may be effective for refractory major depressive disorder. Copyright 2012 BMJ Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Tobe, E. H. (2012). Tianeptine in combination with monoamine oxidase inhibitors for major depressive disorder. BMJ Case Reports. https://doi.org/10.1136/bcr-2012-007044

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free